Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet-induced metabolic syndrome: Pharmacological and metabolism-based investigation

Pharmacological Research

Volumn 117, Issue , 2017, Pages 32-45

  Poudyal, Hemant ^a,b   Lemonakis, Nikolaos ^c   Efentakis, Panagiotis ^c   Gikas, Evangelos ^c   Halabalaki, Maria ^c   Andreadou, Ioanna ^c   Skaltsounis, Leandros ^c   Brown, Lindsay ^b  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cardiovascular; Hydroxytyrosol; Metabolic syndrome; Obesity; Olive oil; Olives

Indexed keywords

BIOLOGICAL MARKER; DRUG METABOLITE; FRUCTOSE; HYDROXYTYROSOL; OLIVE OIL; STARCH; 3,4-DIHYDROXYPHENYLETHANOL; PHENETHYL ALCOHOL;

ABDOMINAL OBESITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BODY COMPOSITION; CARBOHYDRATE DIET; CARDIOMETABOLIC RISK; CELL INFILTRATION; CONTROLLED STUDY; DIET INDUCED OBESITY; DRUG ABSORPTION; DRUG METABOLISM; ENDOTHELIAL DYSFUNCTION; GLUCOSE TOLERANCE; HEART FUNCTION; HEART PROTECTION; IMPAIRED GLUCOSE TOLERANCE; INSULIN TOLERANCE TEST; LIPID BLOOD LEVEL; LIPID DIET; LIVER FUNCTION; LIVER INJURY; LIVER STRUCTURE; LOW FAT DIET; MACROPHAGE; MALE; MASS SPECTROMETRY; METABOLIC SYNDROME X; MONOCYTE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; ANALOGS AND DERIVATIVES; ANIMAL; CARDIOVASCULAR SYSTEM; DISEASE MODEL; DRUG EFFECTS; FAT INTAKE; LIVER; METABOLISM; OBESITY; WISTAR RAT;

ANIMALS; BIOMARKERS; CARDIOVASCULAR SYSTEM; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; DIETARY FATS; DISEASE MODELS, ANIMAL; LIVER; MALE; METABOLIC SYNDROME; OBESITY; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; RATS; RATS, WISTAR;

EID: 85006266086     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.12.002     Document Type: Article

References (51)

1. [1] Babio, N., Bullo, M., Salas-Salvado, J., Mediterranean diet and metabolic syndrome: the evidence. Public Health Nutr. 12:9A (2009), 1607–1617.
2. [2] Gillingham, L.G., Harris-Janz, S., Jones, P.J., Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 46:3 (2011), 209–228.
3. [3] Keys, A., Menotti, A., Karvonen, M.J., Aravanis, C., Blackburn, H., Buzina, R., Djordjevic, B.S., Dontas, A.S., Fidanza, F., Keys, M.H., et al. The diet and 15-year death rate in the Seven Countries Study. Am. J. Epidemiol. 124:6 (1986), 903–915.
4. [4] Panagiotakos, D.B., Pitsavos, C., Polychronopoulos, E., Chrysohoou, C., Zampelas, A., Trichopoulou, A., Can a Mediterranean diet moderate the development and clinical progression of coronary heart disease? A systematic review. Med. Sci. Monit. 10:8 (2004), RA193–8.
5. [5] Poudyal, H., Campbell, F., Brown, L., Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J. Nutr. 140:5 (2010), 946–953.
6. [6] Harika, R.K., Eilander, A., Alssema, M., Osendarp, S.J., Zock, P.L., Intake of fatty acids in general populations worldwide does not meet dietary recommendations to prevent coronary heart disease: a systematic review of data from 40 countries. Ann. Nutr. Metab. 63:3 (2013), 229–238.
7. [7] Visioli, F., Bernardini, E., Extra virgin olive oil's polyphenols: biological activities. Curr. Pharm. Des. 17:8 (2011), 786–804.
8. [8] Lopez-Miranda, J., Perez-Jimenez, F., Ros, E., De Caterina, R., Badimon, L., Covas, M.I., Escrich, E., Ordovas, J.M., Soriguer, F., Abia, R., de la Lastra, C.A., Battino, M., Corella, D., Chamorro-Quiros, J., Delgado-Lista, J., Giugliano, D., Esposito, K., Estruch, R., Fernandez-Real, J.M., Gaforio, J.J., La Vecchia, C., Lairon, D., Lopez-Segura, F., Mata, P., Menendez, J.A., Muriana, F.J., Osada, J., Panagiotakos, D.B., Paniagua, J.A., Perez-Martinez, P., Perona, J., Peinado, M.A., Pineda-Priego, M., Poulsen, H.E., Quiles, J.L., Ramirez-Tortosa, M.C., Ruano, J., Serra-Majem, L., Sola, R., Solanas, M., Solfrizzi, V., de la Torre-Fornell, R., Trichopoulou, A., Uceda, M., Villalba-Montoro, J.M., Villar-Ortiz, J.R., Visioli, F., Yiannakouris, N., Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr. Metab. Cardiovasc. Dis. 20:4 (2010), 284–294.
9. [9] Perez-Jimenez, F., Ruano, J., Perez-Martinez, P., Lopez-Segura, F., Lopez-Miranda, J., The influence of olive oil on human health: not a question of fat alone. Mol. Nutr. Food Res. 51:10 (2007), 1199–1208.
10. [10] EFSA Panel on Dietetic Products, Allergies, Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), anti-inflammatory properties (ID 1882), contributes to the upper respiratory tract health (ID 3468), can help to maintain a normal function of gastrointestinal tract (3779), and contributes to body defences against external agents (ID 3467) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal 9(4) (2011) n/a-n/a.
11. [11] Zrelli, H., Matsuoka, M., Kitasaki, S., Araki, M., Kusunoki, M., Zarrouk, M., Miyazaki, H., Hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction. J. Agric. Food Chem. 59:9 (2011), 4473–4482.
12. [12] Corona, G., Tzounis, X., Assunta Dessi, M., Deiana, M., Debnam, E.S., Visioli, F., Spencer, J.P., The fate of olive oil polyphenols in the gastrointestinal tract: implications of gastric and colonic microflora-dependent biotransformation. Free Radic. Res. 40:6 (2006), 647–658.
13. [13] Manna, C., Migliardi, V., Golino, P., Scognamiglio, A., Galletti, P., Chiariello, M., Zappia, V., Oleuropein prevents oxidative myocardial injury induced by ischemia and reperfusion. J. Nutr. Biochem. 15:8 (2004), 461–466.
14. [14] Andreadou, I., Iliodromitis, E.K., Mikros, E., Constantinou, M., Agalias, A., Magiatis, P., Skaltsounis, A.L., Kamber, E., Tsantili-Kakoulidou, A., Kremastinos, D.T., The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J. Nutr. 136:8 (2006), 2213–2219.
15. [15] Barbaro, B., Toietta, G., Maggio, R., Arciello, M., Tarocchi, M., Galli, A., Balsano, C., Effects of the olive-derived polyphenol oleuropein on human health. Int. J. Mol. Sci. 15:10 (2014), 18508–18524.
16. [16] Cao, K., Xu, J., Zou, X., Li, Y., Chen, C., Zheng, A., Li, H., Li, H., Szeto, I.M., Shi, Y., Long, J., Liu, J., Feng, Z., Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice. Free Radic. Biol. Med. 67 (2014), 396–407.
17. [17] Zheng, A., Li, H., Xu, J., Cao, K., Li, H., Pu, W., Yang, Z., Peng, Y., Long, J., Liu, J., Feng, Z., Hydroxytyrosol improves mitochondrial function and reduces oxidative stress in the brain of db/db mice: role of AMP-activated protein kinase activation. Br. J. Nutr. 113:11 (2015), 1667–1676.
18. [18] Crespo, M.C., Tome-Carneiro, J., Burgos-Ramos, E., Loria Kohen, V., Espinosa, M.I., Herranz, J., Visioli, F., One-week administration of hydroxytyrosol to humans does not activate Phase II enzymes. Pharmacol. Res. 95-96 (2015), 132–137.
19. [19] Castaner, O., Covas, M.I., Khymenets, O., Nyyssonen, K., Konstantinidou, V., Zunft, H.F., de la Torre, R., Munoz-Aguayo, D., Vila, J., Fito, M., Protection of LDL from oxidation by olive oil polyphenols is associated with a downregulation of CD40-ligand expression and its downstream products in vivo in humans. Am. J. Clin. Nutr. 95:5 (2012), 1238–1244.
20. [20] Panchal, S.K., Poudyal, H., Iyer, A., Nazer, R., Alam, M.A., Diwan, V., Kauter, K., Sernia, C., Campbell, F., Ward, L., Gobe, G., Fenning, A., Brown, L., High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J. Cardiovasc. Pharmacol. 57:5 (2011), 611–624.
21. [21] Xynos, N., Abatis, D., Argyropoulou, A., Polychronopoulos, P., Aligiannis, N., Skaltsounis, A.L., Development of a sustainable procedure for the recovery of hydroxytyrosol from table olive processing wastewater using adsorption resin technology and centrifugal partition chromatography. Planta Med. 81:17 (2015), 1621–1627.
22. [22] Poudyal, H., Panchal, S.K., Waanders, J., Ward, L., Brown, L., Lipid redistribution by alpha-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats. J. Nutr. Biochem. 23:2 (2012), 153–162.
23. [23] Andreadou, I., Iliodromitis, E., Mikros, E., Bofilis, E., Zoga, A., Constantinou, M., Tsantili-Kakoulidou, A., Kremastinos, D.T., Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic. Biol. Med. 37:4 (2004), 500–510.
24. [24] Efentakis, P., Andreadou, I., Bibli, S.I., Vasileiou, S., Dagres, N., Zoga, A., Lougiakis, N., Kremastinos, D.T., Iliodromitis, E.K., Ranolazine triggers pharmacological preconditioning and postconditioning in anesthetized rabbits through activation of RISK pathway. Eur. J. Pharmacol. 789 (2016), 431–438.
25. [25] Tsovolas, K., Iliodromitis, E.K., Andreadou, I., Zoga, A., Demopoulou, M., Iliodromitis, K.E., Manolaki, T., Markantonis, S.L., Kremastinos, D.T., Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits. Pharmacol. Res. 57:4 (2008), 283–289.
26. [26] Walker, C., Reamy, B.V., Diets for cardiovascular disease prevention: what is the evidence?. Am. Fam. Physician 79:7 (2009), 571–578.
27. [27] Granados-Principal, S., Quiles, J.L., Ramirez-Tortosa, C.L., Sanchez-Rovira, P., Ramirez-Tortosa, M.C., Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr. Rev. 68:4 (2010), 191–206.
28. [28] Martinez-Gonzalez, M.A., Bes-Rastrollo, M., Serra-Majem, L., Lairon, D., Estruch, R., Trichopoulou, A., Mediterranean food pattern and the primary prevention of chronic disease: recent developments. Nut. Rev. 67:Suppl. 1 (2009), S111–S116.
29. [29] Visioli, F., Galli, C., Biological properties of olive oil phytochemicals. Crit. Rev. Food Sci. Nutr. 42:3 (2002), 209–221.
30. [30] Covas, M.I., Olive oil and the cardiovascular system. Pharmacol. Res. 55:3 (2007), 175–186.
31. [31] Huang, C.L., Sumpio, B.E., Olive oil, the mediterranean diet, and cardiovascular health. J. Am. Coll. Surg. 207:3 (2008), 407–416.
32. [32] Pinto, J., Paiva-Martins, F., Corona, G., Debnam, E.S., Jose Oruna-Concha, M., Vauzour, D., Gordon, M.H., Spencer, J.P., Absorption and metabolism of olive oil secoiridoids in the small intestine. Br. J. Nutr. 105:11 (2011), 1607–1618.
33. [33] Gutierrez-Rosales, F., Rios, J.J., Gomez-Rey, M.L., Main polyphenols in the bitter taste of virgin olive oil. Structural confirmation by on-line high-performance liquid chromatography electrospray ionization mass spectrometry. J. Agric. Food Chem. 51:20 (2003), 6021–6025.
34. [34] Bonoli, M., Montanucci, M., Gallina Toschi, T., Lercker, G., Fast separation and determination of tyrosol, hydroxytyrosol and other phenolic compounds in extra-virgin olive oil by capillary zone electrophoresis with ultraviolet-diode array detection. J. Chromatogr. A 1011:1-2 (2003), 163–172.
35. [35] Miro-Casas, E., Covas, M.I., Farre, M., Fito, M., Ortuno, J., Weinbrenner, T., Roset, P., de la Torre, R., Hydroxytyrosol disposition in humans. Clin. Chem. 49:6 Pt 1 (2003), 945–952.
36. [36] Bes-Rastrollo, M., Soares, M.J., Martinez-Gonzalez, M.A., Chapter 96 − olive oil consumption and weight gain. Victor, R.P., Ross, W. Ronald, (eds.) Olives and Olive Oil in Health and Disease Prevention, 2010, Academic Press, San Diego, 895–902.
37. [37] Shiomi, T., Tsutsui, H., Matsusaka, H., Murakami, K., Hayashidani, S., Ikeuchi, M., Wen, J., Kubota, T., Utsumi, H., Takeshita, A., Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109:4 (2004), 544–549.
38. [38] Efentakis, P., Iliodromitis, E.K., Mikros, E., Papachristodoulou, A., Dagres, N., Skaltsounis, A.-L., Andreadou, I., Effects of the olive tree leaf constituents on myocardial oxidative damage and atherosclerosis. Planta Med. 81:8 (2015), 648–654.
39. [39] Scoditti, E., Calabriso, N., Massaro, M., Pellegrino, M., Storelli, C., Martines, G., De Caterina, R., Carluccio, M.A., Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch. Biochem. Biophys. 527:2 (2012), 81–89.
40. [40] Moreno-Luna, R., Munoz-Hernandez, R., Miranda, M.L., Costa, A.F., Jimenez-Jimenez, L., Vallejo-Vaz, A.J., Muriana, F.J., Villar, J., Stiefel, P., Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Am. J. Hypertens. 5:12 (2012), 1299–1304.
41. [41] Poudyal, H., Kumar, S.A., Iyer, A., Waanders, J., Ward, L.C., Brown, L., Responses to oleic, linoleic and alpha-linolenic acids in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. J. Nutr. Biochem. 24:7 (2013), 1381–1392.
42. [42] Visioli, F., Poli, A., Gall, C., Antioxidant and other biological activities of phenols from olives and olive oil. Med. Res. Rev. 22:1 (2002), 65–75.
43. [43] Aunon-Calles, D., Canut, L., Visioli, F., Toxicological evaluation of pure hydroxytyrosol. Food Chem. Toxicol. 55 (2013), 498–504.
44. [44] Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited. FASEB J. 22:3 (2008), 659–661.
45. [45] de Boer, V.C., Dihal, A.A., van der Woude, H., Arts, I.C., Wolffram, S., Alink, G.M., Rietjens, I.M., Keijer, J., Hollman, P.C., Tissue distribution of quercetin in rats and pigs. J. Nutr. 135:7 (2005), 1718–1725.
46. [46] Hoek-van den Hil, E.F., van Schothorst, E.M., van der Stelt, I., Swarts, H.J., Venema, D., Sailer, M., Vervoort, J.J., Hollman, P.C., Rietjens, I.M., Keijer, J., Quercetin decreases high-fat diet induced body weight gain and accumulation of hepatic and circulating lipids in mice. Genes Nutr., 9(5), 2014, 418.
47. [47] Kim, S., Jin, Y., Choi, Y., Park, T., Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem. Pharmacol. 81:11 (2011), 1343–1351.
48. [48] van Schothorst, E.M., Bunschoten, A., Hoevenaars, F.P.M., van der Stelt, I., Janovska, P., Venema, D., Kopecky, J., Hollman, P.C.H., Keijer, J., Direct comparison of health effects by dietary polyphenols at equimolar doses in wildtype moderate high-fat fed C57BL/6JOlaHsd mice. Food Res. Int. 65:Part A (2014), 95–102.
49. [49] D'Angelo, S., Manna, C., Migliardi, V., Mazzoni, O., Morrica, P., Capasso, G., Pontoni, G., Galletti, P., Zappia, V., Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil. Drug Metab. Dispos. 29:11 (2001), 1492–1498.
50. [50] Mateos, R., Goya, L., Bravo, L., Metabolism of the olive oil phenols hydroxytyrosol, tyrosol, and hydroxytyrosyl acetate by human hepatoma HepG2 cells. J. Agric. Food Chem. 53:26 (2005), 9897–9905.
51. [51] Visioli, F., Galli, C., Grande, S., Colonnelli, K., Patelli, C., Galli, G., Caruso, D., Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration. J. Nutr. 133:8 (2003), 2612–2615.